AccurKardia receives patent for AI-ECG cardiac amyloidosis detection

AccurKardia received a U.S. patent for an AI-powered system that detects cardiac amyloidosis from standard 12-lead ECGs. The machine learning technology addresses delayed diagnosis in a disease area where early detection is challenging, expanding the company's AI-ECG analytics pipeline.